Page 439 - Feline Cardiology
P. 439

464  Section R: Drug Formulary



               Generic Name    Indications/Drug   Dosage and   Comments                           Available sizes
               (Brand Name)    Type            Possible Routes
                                               of Admin.

               Warfarin        Vitamin K       0.25–0.6 mg/  Powerful orally active anticoagulant indicated   1, 2, 2.5, 3, 4,
               (Coumadin [H])  antagonizing    cat           for prevention of recurrent thromboembolism.   5, 6, 7.5, 10 mg
                               anticoagulant   PO q 24h      Variable efficacy, including either inadequate   T
                                                             or excessive anticoagulation; anticoagulant   HM
                                                             effect is optimized via weekly plasma
                                                             prothrombin time measurement, targeting
                                                             1.5–2.5 times upper limit of normal. Subjectively
                                                             the most effective anticoagulant in feline
                                                             medicine but also the most prone to
                                                             adverse effects. Brief period of inhibition of
                                                             proteins C and S (natural anticoagulants) at
                                                             onset of treatment suggests transient
                                                             hypercoagulability and warrants overlap
                                                             between injectable (heparin) treatment during
                                                             acute phase of thromboembolism treatment
                                                             (2–4 days) and start of chronic oral warfarin
                                                             treatment. Treatment if signs of excessive
                                                             anticoagulation: stop warfarin; if needed,
                                                             vitamin K (2.5– 3 mg/kg IM or SQ), plus
                                                             plasma transfusion if bleeding. Anticoagulant
                                                             function helps prevent formation of new
                                                             thrombi but does not actively degrade existing
                                                             thrombi.

               Xylocaine—see
               Lidocaine
               Zestril—see
               Lisinopril







              REFERENCES                                           feline  hypertrophic  cardiomyopathy.  Results  of  a  prospective,
                                                                   open-label, multicenter clinical trial. J Vet Cardiol 1999;1:19–26.
              Reference citations are listed alphabetically by name of first author;
              the  headings  in  italic  font  identify  the  drug(s)  discussed  in  each   Aspirin, Furosemide, Digoxin
              reference.                                         Atkins CE, Snyder PS, Keene BW. Effect of aspirin, furosemide, and
                                                                   commercial low-salt diet on digoxin pharmacokinetic properties
              Heparin-LMWH                                         in clinically normal cats. J Am Vet Med Assoc 1088;193:1264–1268.
              Alwood AJ, Downend AB, Brooks MB, Slensky KA, Fox JA, Simpson
                 SA, Waddell LS, Otto CM. Anticoagulant effects of low-molecular-  Digoxin
                 weight heparins in healthy cats (abstract). J Vet Emerg Crit Care   Atkins CE, Snyder PS, Keene BW, Rush JE. Effects of compensated
                 2004;14:S1.                                       heart failure on digoxin pharmacokinetics in cats. J Am Vet Med
                                                                   Assoc 1989;195:945–950.
      Drug Formulary  Alwood AJ, Downend AB, Brooks MB, Slensky KA, Fox JA, Simpson   Atkins CE, Snyder PS, Keene BW, Rush JE, Eicker S. Efficacy of digoxin
              Heparin-LMWH
                                                                 Digoxin
                 SA, Waddell LS, Baumgardner JE, Otto CM. Anticoagulant effects
                                                                   for treatment of cats with dilated cardiomyopathy. J Am Vet Med
                 of low-molecular-weight heparins in healthy cats. J Vet Intern Med
                                                                   Assoc 1990;196:1463–1469.
                 2007;21:378–387.
              Benazepril                                         Lactated Ringer’s solution
                                                                 Bjorling DE, Rawlings CA. Relationship of intravenous administra-
              Amberger CN, Glardon O, Glaus T, Hörauf A, King JN, Schmidli H,   tion of Ringer’s lactate solution to pulmonary edema in halothane-
                 Schröter L, Lombard CW. Effects of benazepril in the treatment of   anesthetized cats. Am J Vet Res 1983;44: 1000–1006.
   434   435   436   437   438   439   440   441   442   443   444